153 related articles for article (PubMed ID: 38056145)
1. Madecassoside alleviates acute kidney injury by regulating JNK-mediated oxidative stress and programmed cell death.
Shan RR; Yu JT; Zhang SF; Xie MM; Hou R; Xie CY; Dong ZH; Yang Q; Hu XW; Dong YH; Zhang Y; Luo XF; Cui ZY; Liu XY; Xie YC; Wen JG; Liu MM; Jin J; Chen Q; Meng XM
Phytomedicine; 2024 Jan; 123():155252. PubMed ID: 38056145
[TBL] [Abstract][Full Text] [Related]
2. Madecassoside ameliorates cisplatin-induced nephrotoxicity by inhibiting activation of the mitogen activated protein kinase pathway.
Yuan H; Zhao Y; Li S; Qin J; Yu X
Environ Toxicol; 2023 Jul; 38(7):1473-1483. PubMed ID: 37087747
[TBL] [Abstract][Full Text] [Related]
3. Gypenoside XLIX protects against acute kidney injury by suppressing IGFBP7/IGF1R-mediated programmed cell death and inflammation.
Yang Q; Zang HM; Xing T; Zhang SF; Li C; Zhang Y; Dong YH; Hu XW; Yu JT; Wen JG; Jin J; Li J; Zhao R; Ma TT; Meng XM
Phytomedicine; 2021 May; 85():153541. PubMed ID: 33773190
[TBL] [Abstract][Full Text] [Related]
4. Protective effect of taraxasterol on ischemia/reperfusion-induced acute kidney injury via inhibition of oxidative stress, inflammation, and apoptosis.
Li C; Zheng Z; Xie Y; Zhu N; Bao J; Yu Q; Zhou Z; Liu J
Int Immunopharmacol; 2020 Dec; 89(Pt A):107169. PubMed ID: 33183976
[TBL] [Abstract][Full Text] [Related]
5. Network pharmacology and experimental validation to investigate the mechanism of Nao-Ling-Su capsule in the treatment of ischemia/reperfusion-induced acute kidney injury.
Lin Y; Xu L; Lin H; Cui W; Jiao Y; Wang B; Li H; Wang X; Wu J
J Ethnopharmacol; 2024 May; 326():117958. PubMed ID: 38395179
[TBL] [Abstract][Full Text] [Related]
6. Rutaecarpine derivative Cpd-6c alleviates acute kidney injury by targeting PDE4B, a key enzyme mediating inflammation in cisplatin nephropathy.
Liu XQ; Jin J; Li Z; Jiang L; Dong YH; Cai YT; Wu MF; Wang JN; Ma TT; Wen JG; Liu MM; Li J; Wu YG; Meng XM
Biochem Pharmacol; 2020 Oct; 180():114132. PubMed ID: 32622666
[TBL] [Abstract][Full Text] [Related]
7. Baicalein alleviates cisplatin-induced acute kidney injury by inhibiting ALOX12-dependent ferroptosis.
Guo S; Zhou L; Liu X; Gao L; Li Y; Wu Y
Phytomedicine; 2024 Jul; 130():155757. PubMed ID: 38805781
[TBL] [Abstract][Full Text] [Related]
8. Tubular transcriptional co-activator with PDZ-binding motif protects against ischemic acute kidney injury.
Wu CL; Chang CC; Yang TH; Tsai AC; Wang JL; Chang CH; Tarng DC
Clin Sci (Lond); 2020 Jul; 134(13):1593-1612. PubMed ID: 32558891
[TBL] [Abstract][Full Text] [Related]
9. Hexarelin alleviates apoptosis on ischemic acute kidney injury via MDM2/p53 pathway.
Guan C; Li C; Shen X; Yang C; Liu Z; Zhang N; Xu L; Zhao L; Zhou B; Man X; Luo C; Luan H; Che L; Wang Y; Xu Y
Eur J Med Res; 2023 Sep; 28(1):344. PubMed ID: 37710348
[TBL] [Abstract][Full Text] [Related]
10. Hederagenin ameliorates cisplatin-induced acute kidney injury via inhibiting long non-coding RNA A330074k22Rik/Axin2/β-catenin signalling pathway.
Xie KH; Liu XH; Jia J; Zhong X; Han RY; Tan RZ; Wang L
Int Immunopharmacol; 2022 Nov; 112():109247. PubMed ID: 36155281
[TBL] [Abstract][Full Text] [Related]
11. DRD4 alleviates acute kidney injury by suppressing ISG15/NOX4 axis-associated oxidative stress.
Gao Y; Lu X; Zhang G; Liu C; Sun S; Mao W; Jiang G; Zhou Y; Zhang N; Tao S; Chen M; Chen S; Zhang L
Redox Biol; 2024 Apr; 70():103078. PubMed ID: 38354631
[TBL] [Abstract][Full Text] [Related]
12. Dl-3-n-butylphthalide pretreatment attenuates renal ischemia/reperfusion injury.
Dong Y; Yin J; Chen T; Wen J; Zhang Q; Li X; Lin W; Liu F; Fan Y; Wang N
Biochem Biophys Res Commun; 2021 Jun; 557():166-173. PubMed ID: 33865225
[TBL] [Abstract][Full Text] [Related]
13. Conditional knockout of TGF-βRII /Smad2 signals protects against acute renal injury by alleviating cell necroptosis, apoptosis and inflammation.
Yang Q; Ren GL; Wei B; Jin J; Huang XR; Shao W; Li J; Meng XM; Lan HY
Theranostics; 2019; 9(26):8277-8293. PubMed ID: 31754396
[No Abstract] [Full Text] [Related]
14. Meclofenamic acid promotes cisplatin-induced acute kidney injury by inhibiting fat mass and obesity-associated protein-mediated m
Zhou P; Wu M; Ye C; Xu Q; Wang L
J Biol Chem; 2019 Nov; 294(45):16908-16917. PubMed ID: 31578283
[TBL] [Abstract][Full Text] [Related]
15. Renal Tubular Epithelial TRPA1 Acts as An Oxidative Stress Sensor to Mediate Ischemia-Reperfusion-Induced Kidney Injury through MAPKs/NF-κB Signaling.
Wu CK; Wu CL; Lee TS; Kou YR; Tarng DC
Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33669091
[TBL] [Abstract][Full Text] [Related]
16. RIPK1 inhibitor Cpd-71 attenuates renal dysfunction in cisplatin-treated mice via attenuating necroptosis, inflammation and oxidative stress.
Wang JN; Liu MM; Wang F; Wei B; Yang Q; Cai YT; Chen X; Liu XQ; Jiang L; Li C; Hu XW; Yu JT; Ma TT; Jin J; Wu YG; Li J; Meng XM
Clin Sci (Lond); 2019 Jul; 133(14):1609-1627. PubMed ID: 31315969
[TBL] [Abstract][Full Text] [Related]
17. Restoration of E-cadherin by PPBICA protects against cisplatin-induced acute kidney injury by attenuating inflammation and programmed cell death.
Gao L; Liu MM; Zang HM; Ma QY; Yang Q; Jiang L; Ren GL; Li HD; Wu WF; Wang JN; Wei B; Liu XQ; Jiang C; Huang C; Li J; Meng XM
Lab Invest; 2018 Jul; 98(7):911-923. PubMed ID: 29581579
[TBL] [Abstract][Full Text] [Related]
18. PIM1 attenuates renal ischemia-reperfusion injury by inhibiting ASK1-JNK/P38.
Luo Y; Zhu J; Zhao F; Shi L; Li Y; Wu X
Int Immunopharmacol; 2023 Jan; 114():109563. PubMed ID: 36513021
[TBL] [Abstract][Full Text] [Related]
19. VASPIN reduces inflammation and endoplasmic reticulum stress of renal tubular epithelial cells by inhibiting HMGB1 and relieves renal ischemia-reperfusion injury.
Zhang GZ; Zhang K; Yang SQ; Zhang Z; Chen S; Hou BJ; Yuan JY
Eur Rev Med Pharmacol Sci; 2020 Sep; 24(17):8968-8977. PubMed ID: 32964986
[TBL] [Abstract][Full Text] [Related]
20. Oligosaccharides Ameliorate Acute Kidney Injury by Alleviating Cluster of Differentiation 44-Mediated Immune Responses in Renal Tubular Cells.
Chen TH; Liu CT; Cheng CY; Sue YM; Huang NJ; Chen CH
Nutrients; 2022 Feb; 14(4):. PubMed ID: 35215410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
